InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the detailed record of transactions filed by Deardorf Caren, Directeur Commercial. Officer active across 1 companies, notably Magenta Therapeutics, Inc.. Cumulatively, 5 disclosures have been logged. Total volume traded: €71k. The latest transaction was filed on 31 May 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
€2,7673,000 shares@ €0.92233.7% of flow
Common Stock
SEC:0000899243-22-021185:0·
€35,6766,238 shares@ €5.7192100.0% of flow
Common Stock
SEC:0000899243-21-036600·
€35,6766,238 shares@ €5.719248.1% of flow
Common Stock
SEC:0000899243-21-036600:0·
020,000 shares0
Common Stock
SEC:0000899243-21-036338·
020,000 shares0
Common Stock
SEC:0000899243-21-036338:0·
5 of 5 declarations
About Deardorf Caren
Caren Deardorf is the Chief Commercial Officer at Magenta Therapeutics, Inc. She is responsible for the company's commercial strategy and revenue growth. With extensive experience in the industry, she leads business development initiatives and strategic partnerships. Her role is crucial in positioning Magenta Therapeutics as a leader in its field, ensuring alignment between business objectives and market needs.
